pargyline has been researched along with unc 0638 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassandri, M; Cilli, D; Del Bufalo, D; Fiorentino, F; Lucidi, A; Mai, A; Marrocco, B; Mattevi, A; Menna, M; Minucci, S; Mladenović, M; Pezzella, M; Pomella, S; Romanenghi, M; Rota, R; Rotili, D; Sbardella, G; Tomašević, N; Tomassi, S; Trisciuoglio, D; Viviano, M; Zeya Ansari, MS | 1 |
1 other study(ies) available for pargyline and unc 0638
| Article | Year |
|---|---|
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.
Topics: Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia | 2022 |